These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 22907940)

  • 1. MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
    Jernås M; Malmeström C; Axelsson M; Olsson C; Nookaew I; Wadenvik H; Zetterberg H; Blennow K; Lycke J; Rudemo M; Olsson B
    Mult Scler; 2013 Apr; 19(4):403-10. PubMed ID: 22907940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.
    Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F
    J Neuroinflammation; 2015 Jul; 12():132. PubMed ID: 26169064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
    Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
    J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF.
    Malmeström C; Lycke J; Haghighi S; Andersen O; Carlsson L; Wadenvik H; Olsson B
    J Neuroimmunol; 2008 May; 196(1-2):159-65. PubMed ID: 18396337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
    Dong-Si T; Weber J; Liu YB; Buhmann C; Bauer H; Bendl C; Schnitzler P; Grond-Ginsbach C; Grau AJ
    J Neurol; 2004 May; 251(5):542-7. PubMed ID: 15164186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of leukemia inhibitory factor in the cerebrospinal fluid of patients with multiple sclerosis.
    Mashayekhi F; Salehi Z
    J Clin Neurosci; 2011 Jul; 18(7):951-4. PubMed ID: 21570299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
    Gurevich M; Achiron A
    J Neuroimmunol; 2012 Nov; 252(1-2):83-8. PubMed ID: 22921736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis.
    Sotelo J; Martínez-Palomo A; Ordoñez G; Pineda B
    Ann Neurol; 2008 Mar; 63(3):303-11. PubMed ID: 18306233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
    J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.
    Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
    Hum Mol Genet; 2011 Sep; 20(18):3606-19. PubMed ID: 21676896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.
    Haghikia A; Haghikia A; Hellwig K; Baraniskin A; Holzmann A; Décard BF; Thum T; Gold R
    Neurology; 2012 Nov; 79(22):2166-70. PubMed ID: 23077021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor V beta gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosis.
    Chou YK; Buenafe AC; Dedrick R; Morrison WJ; Bourdette DN; Whitham R; Atherton J; Lane J; Spoor E; Hashim GA
    J Neurosci Res; 1994 Feb; 37(2):169-81. PubMed ID: 7512148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
    Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
    Giacomini E; Severa M; Rizzo F; Mechelli R; Annibali V; Ristori G; Riccieri V; Salvetti M; Coccia EM
    Eur J Immunol; 2013 Jul; 43(7):1963-72. PubMed ID: 23636665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis of interferon-beta treatment in multiple sclerosis.
    Sellebjerg F; Datta P; Larsen J; Rieneck K; Alsing I; Oturai A; Svejgaard A; Soelberg Sørensen P; Ryder LP
    Mult Scler; 2008 Jun; 14(5):615-21. PubMed ID: 18408020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
    Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
    Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
    Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
    Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
    Achiron A; Gurevich M; Snir Y; Segal E; Mandel M
    Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.